Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

By Kaji Kosuke   Yoshiji Hitoshi   Ikenaka Yasuhide   Noguchi Ryuichi   Aihara Yosuke   Douhara Akitoshi   Moriya Kei   Kawaratani Hideto   Shirai Yusaku   Yoshii Junichi   Yanase Koji   Kitade Mitsuteru   Namisaki Tadashi   Fukui Hiroshi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 481-491

Springer Publishing Company

Access to resources Recommend Favorite

Development of Human‐Like Advanced Coronary Plaques in Low‐Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 173-177

Bentham Science Publishers

Access to resources Recommend Favorite

Soluble Low-Density Lipoprotein Receptor-Related Protein - a multiligand receptor for lipoprotein and proteinase catabolism

By Grimsley P.G.   Quinn K.A.   Owensby D.A.  

Trends in Cardiovascular Medicine, Vol. 8, Iss. 8, 1998-11 ,pp. : 363-368

Elsevier

Access to resources Recommend Favorite

Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients

By  

Current Vascular Pharmacology, Vol. 14, Iss. 6, 2016-10 ,pp. : 552-562

Bentham Science Publishers

Access to resources Recommend Favorite